Table 4.
Distribution of genotypes and allele frequency in the RAD51, RAD51B, XRCC2, and XRCC3 loci among prostate cancer patients.
| Gene | Genotype/allele | Prostate cancer patients (n = 101) |
Control group (n = 216) |
P |
|---|---|---|---|---|
|
RAD51
rs1801320 |
GG | 66 | 172 | 0.017 |
| GC | 27 | 37 | ||
| CC | 8 | 7 | ||
| G | 159 | 381 | 0.002 | |
| C | 43 | 51 | ||
| rs1801321 | GG | 39 | 67 | 0.392 |
| TG | 4 | 8 | ||
| TT | 58 | 141 | ||
| G | 82 | 421 | 0.058 | |
| T | 120 | 290 | ||
|
| ||||
|
RAD51B
rs10483813 |
TT | 56 | 134 | 0.350 |
| TA | 40 | 68 | ||
| AA | 5 | 14 | ||
| T | 152 | 336 | 0.481 | |
| A | 50 | 96 | ||
| rs3784099 | GG | 49 | 122 | 0.225 |
| GA | 41 | 80 | ||
| AA | 11 | 14 | ||
| G | 139 | 324 | 0.102 | |
| A | 63 | 108 | ||
|
| ||||
|
XRCC2
rs3218536 |
GG | 90 | 196 | 0.648 |
| GA | 11 | 20 | ||
| AA | 0 | 0 | ||
| G | 191 | 412 | 0.800 | |
| A | 11 | 20 | ||
|
| ||||
|
XRCC3
rs861539 |
CC | 54 | 119 | 0.776 |
| CT | 34 | 75 | ||
| TT | 13 | 22 | ||
| C | 142 | 313 | 0.574 | |
| T | 60 | 119 | ||